Oct 7, 2026 08:00AM
Oct 7, 2026 08:00AM
Sep 2, 2025 07:47AM
Nov 2, 2023 06:31AM
Nov 2, 2023 06:30AM
Sep 1, 2021 01:44PM
Aug 6, 2021 06:30AM Immunic, Inc. Reports Second Quarter 2021 Financial Results and Highlights Recent Activity
Jul 1, 2021 06:31AM
Jul 1, 2021 06:30AM
May 6, 2021 06:30AM
Apr 15, 2021 06:31AM
Apr 15, 2021 06:30AM
Feb 18, 2021 06:45AM
Feb 18, 2021 06:30AM Immunic, Inc. Announces Positive Top-Line Data From Investigator-Sponsored Phase 2 Proof-of-Concept Clinical Trial of IMU-838 in Primary Sclerosing Cholangitis
Nov 17, 2020 06:30AM
Nov 2, 2020 06:38AM
Nov 2, 2020 06:30AM
Sep 4, 2020 12:00AM
Aug 26, 2020 09:23AM
Aug 3, 2020 09:31AM
Jul 20, 2020 09:33AM Pre-Open Movers 07/20: (SRNE) (BNTX) (NBL) Higher; (NKLA) (MRNA) Lower (more...)
Jun 15, 2020 06:30AM
Jun 15, 2020 06:30AM
Jun 9, 2020 07:04AM
Jun 9, 2020 07:00AM
May 11, 2020 09:28AM
Sep 5, 2019 04:01PM
Sep 5, 2019 04:00PM Immunic, Inc.'s Interim Dosing Analysis of IMU-838 as Part of its Ongoing Phase 2 CALDOSE-1 Study in Patients with Moderate-to-Severe Ulcerative Colitis Establishes Broad, Potentially Safe and Effecti
Aug 12, 2019 06:30AM
Jul 11, 2019 08:55AM
Apr 23, 2019 06:59AM

334,273 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All